HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Aradhana Prajapati Selected Research

purmorphamine

3/2022Smo-Shh Agonist Purmorphamine Prevents Neurobehavioral and Neurochemical Defects in 8-OH-DPAT-Induced Experimental Model of Obsessive-Compulsive Disorder.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Aradhana Prajapati Research Topics

Disease

1Acquired Immunodeficiency Syndrome (AIDS)
06/2022
1Autistic Disorder (Autism)
06/2022
1Bipolar Disorder (Manic Depressive Psychosis)
04/2022
1Mitochondrial Diseases (Mitochondrial Disease)
04/2022
1Inflammation (Inflammations)
03/2022
1Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive)
03/2022
1Huntington Disease (Huntington's Disease)
01/2022
1Alzheimer Disease (Alzheimer's Disease)
01/2022
1Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
01/2022
1Brain Diseases (Brain Disorder)
01/2022
1Parkinson Disease (Parkinson's Disease)
01/2022
1Schizophrenia (Dementia Praecox)
01/2022

Drug/Important Bio-Agent (IBA)

2Neurotransmitter Agents (Neurotransmitter)IBA
04/2022 - 03/2022
1PPAR gammaIBA
06/2022
1PPAR-gamma AgonistsIBA
06/2022
18-Hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT)IBA
03/2022
1Neuroprotective AgentsIBA
03/2022
1purmorphamineIBA
03/2022
1Myelin Basic ProteinIBA
01/2022
1mangostinIBA
01/2022